Pharmacovigilance study of tyrosine kinase inhibitors: Analysis of adverse reactions

• Egile Nagusiak: Antoan Rangelov (Egilea), Georgi Momekov (Egilea), Iva Parvova (Egilea), Emil Hristov (Egilea), Boris Kadinov (Egilea), Lyubomir Marinov (Egilea)
• Formatua: Liburua
• Argitaratua: Pensoft Publishers, 2024-11-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

The aim of the study is to analyze reports of adverse drug reactions published in the scientific literature occurring during and after the use of kinase inhibitors for the treatment of rheumatologic diseases to determine their type, frequency, and severity. The search was conducted in the MEDLINE an...